Skip to content

A Clinical research to evaluate the beneficial effect of Leech application in piles.

â??Evaluation of the effect of Irsal-e Alaq( Leech Therapy) in Bawaseer (Haemorrhoids) â?? An open labelled observational study "

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012326
Enrollment
20
Registered
2018-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Lower GIT (Haemorrhoid)

Interventions

Intervention1: Leech therapy (Hirudinaria granulose): Leech therapy (Hirudinaria granulose)was used as a treatment procedure, after taking written informed consent, 2-3 leeches (Hirudinaria granulose)

Sponsors

National Institute of Unani Medicine Bengaluru
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Haemodynamically stable and diagnosed patients of 3rd and 4thdegree Haemorrhoid with the complaining of per rectal bleeding after defecation, Ano-rectal itching after defecation and Pain in anorectal region Patient of both genders Patients in age groups of 20-60 years Patient able to participate in the study and ready to follow the instructions and sign the consent form

Exclusion criteria

Exclusion criteria: Patients of 1st and 2nd degree Haemorrhoids Patients of coagulation disorders Hypertensive patients Diabetes mellitus Severe systemic illness Pregnant and lactating women Secondary Haemorrhoids

Design outcomes

Primary

MeasureTime frame
Mean of per rectal bleeding after defecation, Ano-rectal itching after defecation and Pain in anorectal region before and end of treatment (after 28 days)Timepoint: 28 days

Secondary

MeasureTime frame
COloRectal Evaluation of Clinical Therapeutics Scaleâ?? (CORECTS) for pain, itching, swelling, bleeding and discomfort and â??Impact on Well-being (IW)â?? score.Timepoint: 28 days

Countries

India

Contacts

Public ContactAbdul Mobeen

National Institute of Unani Medicine (NIUM)

dr.mobeen@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026